Veracyte Q4 Earnings Beat Estimates, Revenues Grow Y/Y, Stock RisesZacks Investment Research • 02/26/26
Veracyte (VCYT) Loses 20.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 02/05/26
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026Business Wire • 02/04/26
Veracyte, Inc. (VCYT) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/15/26
Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule TestingBusiness Wire • 11/03/25
Veracyte (VCYT) Crossed Above the 20-Day Moving Average: What That Means for InvestorsZacks Investment Research • 10/16/25